Last visit was: 08 May 2026, 04:30 It is currently 08 May 2026, 04:30
More Filters
School
Status
Round
Year
GMAT GRE
GPA
YOE
Years of Experiance
Post-MBA industry
Location
Date
Full Time MBA
Admitted
Round 2 2023 3 Consulting
04 May 2023 12:21 AM
Full Time MBA
Admitted
Round 2 2023 325 GRE 0 Nigeria
04 May 2023 12:20 AM
MIT Executive MBA
Admitted
2023 3.6 13 United States
04 May 2023 12:16 AM
Full Time MBA
Waitlisted with Interview
Round 1 2023 3 Consulting
04 May 2023 12:11 AM
Full Time MBA
Waitlisted without Interview
Round 2 2023 3 Consulting
04 May 2023 12:07 AM
Full Time MBA
Invited to Interview
Round 2 2023 730 GMAT Classic 4 India
04 May 2023 12:06 AM
Full Time MBA
Invited to Interview
Round 2 2023 730 GMAT Classic
760 GMAT Classic
3.4 4 Consulting India
04 May 2023 12:01 AM
Full Time MBA
Denied without Interview
Round 2 2023 3.7 0 China
04 May 2023 12:00 AM
Full Time MBA
Waitlisted without Interview
Round 2 2023 3 Pakistan
03 May 2023 11:59 PM
Full Time MBA
Denied without Interview
Round 2 2023 0 India
03 May 2023 11:58 PM
Full Time MBA
Waitlisted without Interview
Round 2 2023 3 Consulting
03 May 2023 11:57 PM
Full Time MBA
Denied without Interview
Round 2 2023 3 Consulting
03 May 2023 11:55 PM
Full Time MBA
Denied without Interview
Round 2 2023 710 GMAT Classic 3.6 5 United States
03 May 2023 11:52 PM
Full Time MBA
Waitlisted without Interview
Round 2 2023 630 GMAT Classic
640 GMAT Classic
0 Finance: Investment Banking United States
03 May 2023 11:51 PM
Full Time MBA
Denied without Interview
Round 2 2023 320 GRE 3.6 4 Nigeria
03 May 2023 11:49 PM
Full Time MBA
Waitlisted without Interview
Round 2 2023 3 Consulting
03 May 2023 11:38 PM
Full Time MBA
Denied without Interview
Round 2 2023 710 GMAT Classic 6 Pharmaceuticals and Biotech United Kingdom
03 May 2023 11:37 PM
Full Time MBA
Invited to Interview
Round 2 2023 329 GRE 3.3 0 Nigeria
03 May 2023 10:17 PM
Full Time MBA
Invited to Interview
Round 1 2023 3 Consulting
03 May 2023 09:54 PM
Full Time MBA
Denied without Interview
Round 1 2023 730 GMAT Classic 3.4 8 Pharmaceuticals and Biotech Japan
03 May 2023 09:54 PM